| A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food (NCT06624072) | Boehringer Ingelheim | 2024-10-15 |
| Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations (NCT06581432) | Boehringer Ingelheim | 2024-10-11 |
| Natural History of Netherton Syndrome (NCT05902663) | Boehringer Ingelheim | 2024-10-09 |
| A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity (NCT06564441) | Boehringer Ingelheim | 2024-10-01 |
| A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver (NCT05202353) | Boehringer Ingelheim | 2024-10-01 |
| A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body (NCT06572111) | Boehringer Ingelheim | 2024-09-30 |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis (NCT06632444) | Boehringer Ingelheim | 2024-09-17 |
| A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfunction-associated Steatohepatitis (MASH) (NCT06575400) | Boehringer Ingelheim | 2024-09-12 |
| A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) (NCT06335303) | Boehringer Ingelheim | 2024-09-05 |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) (NCT06531824) | Boehringer Ingelheim | 2024-08-30 |
| A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis (NCT06360094) | Boehringer Ingelheim | 2024-08-28 |
| A Study in Healthy Men to Test How BI 1569912 is Processed in the Body (NCT06520553) | Boehringer Ingelheim | 2024-08-26 |
| A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood (NCT06504862) | Boehringer Ingelheim | 2024-08-20 |
| A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men (NCT06494774) | Boehringer Ingelheim | 2024-08-19 |
| A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body (NCT06492135) | Boehringer Ingelheim | 2024-08-12 |
| A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways (NCT06520514) | Boehringer Ingelheim | 2024-08-07 |
| A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer (NCT05963867) | Boehringer Ingelheim | 2024-08-06 |
| A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body (NCT06494761) | Boehringer Ingelheim | 2024-07-30 |
| A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib (NCT06200714) | Boehringer Ingelheim | 2024-07-16 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated (NCT06429137) | Boehringer Ingelheim | 2024-07-08 |
| A Study in Healthy People to Compare Two Different Sifrol® Tablets (NCT06457204) | Boehringer Ingelheim | 2024-07-02 |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread (NCT06324357) | Boehringer Ingelheim | 2024-06-28 |
| Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma (NCT06370871) | Boehringer Ingelheim | 2024-06-27 |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure (NCT06424288) | Boehringer Ingelheim | 2024-06-17 |
| A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity (NCT06352437) | Boehringer Ingelheim | 2024-06-10 |
| A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body (NCT06408870) | Boehringer Ingelheim | 2024-06-06 |
| A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body (NCT06393127) | Boehringer Ingelheim | 2024-06-04 |
| A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food (NCT06415045) | Boehringer Ingelheim | 2024-05-28 |
| A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood (NCT06419660) | Boehringer Ingelheim | 2024-05-22 |
| A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy (NCT06321302) | Boehringer Ingelheim | 2024-05-15 |
| A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems (NCT06352411) | Boehringer Ingelheim | 2024-05-15 |
| A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab (NCT06241573) | Boehringer Ingelheim | 2024-05-08 |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (NCT06238622) | Boehringer Ingelheim | 2024-05-06 |
| A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men (NCT06232252) | Boehringer Ingelheim | 2024-05-06 |
| A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems (NCT06272058) | Boehringer Ingelheim | 2024-05-03 |
| A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity (NCT06352424) | Boehringer Ingelheim | 2024-04-30 |
| A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers (NCT06360081) | Boehringer Ingelheim | 2024-04-30 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated (NCT06310005) | Boehringer Ingelheim | 2024-04-19 |
| A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot (NCT05966740) | Boehringer Ingelheim | 2024-04-19 |
| A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles Midazolam (NCT06327256) | Boehringer Ingelheim | 2024-04-09 |
| A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) (NCT05865886) | Boehringer Ingelheim | 2024-04-05 |
| A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine (NCT06280235) | Boehringer Ingelheim | 2024-03-27 |
| A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity (NCT06200467) | Boehringer Ingelheim | 2024-03-13 |
| Real-world Study of Dedifferentiated Liposarcoma Patients in China (NCT06115681) | Boehringer Ingelheim | 2024-03-13 |
| A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood (NCT06255340) | Boehringer Ingelheim | 2024-03-11 |
| A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities (NCT06107036) | Boehringer Ingelheim | 2024-03-06 |
| A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 (NCT06091930) | Boehringer Ingelheim | 2024-02-16 |
| DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy (NCT05990738) | Boehringer Ingelheim | 2024-02-14 |
| DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer (NCT06077500) | Boehringer Ingelheim | 2024-02-14 |
| Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment (NCT06151574) | Boehringer Ingelheim | 2024-02-09 |
| A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight (NCT06214741) | Boehringer Ingelheim | 2024-02-06 |
| A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3 (NCT05916313) | Boehringer Ingelheim | 2024-01-30 |
| A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety (NCT06070597) | Boehringer Ingelheim | 2024-01-25 |
| DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers (NCT06132113) | Boehringer Ingelheim | 2024-01-22 |
| A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood (NCT06193811) | Boehringer Ingelheim | 2024-01-16 |
| A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease (NCT06176365) | Boehringer Ingelheim | 2024-01-16 |
| A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly (NCT06082843) | Boehringer Ingelheim | 2024-01-03 |
| Safety of Nintedanib in Real World in China (NCT05676112) | Boehringer Ingelheim | 2023-12-29 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated (NCT06148948) | Boehringer Ingelheim | 2023-12-25 |
| A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood (NCT05896384) | Boehringer Ingelheim | 2023-12-21 |
| A Study to Test How Different Doses of Nerandomilast (BI 1015550) Are Taken up in the Body of Healthy Japanese Men (NCT06139302) | Boehringer Ingelheim | 2023-12-20 |
| Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma (NCT06058793) | Boehringer Ingelheim | 2023-12-13 |
| A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body (NCT06166992) | Boehringer Ingelheim | 2023-12-12 |
| A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus (NCT06056024) | Boehringer Ingelheim | 2023-12-06 |
| Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors (NCT05855109) | Boehringer Ingelheim | 2023-11-27 |
| A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (NCT06066528) | Boehringer Ingelheim | 2023-11-27 |
| A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (NCT06066515) | Boehringer Ingelheim | 2023-11-25 |
| A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) (NCT06077864) | Boehringer Ingelheim | 2023-11-20 |
| Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France (NCT05882071) | Boehringer Ingelheim | 2023-11-15 |
| A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood (NCT06070610) | Boehringer Ingelheim | 2023-11-08 |
| A Study in Healthy Men to Test How Zongertinib is Taken up in the Body When Taken With or Without Food (NCT06075277) | Boehringer Ingelheim | 2023-10-19 |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers (NCT05882058) | Boehringer Ingelheim | 2023-10-13 |
| A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis (NCT05741385) | Boehringer Ingelheim | 2023-10-10 |
| A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood (NCT06041438) | Boehringer Ingelheim | 2023-09-29 |
| A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated (NCT05985200) | Boehringer Ingelheim | 2023-09-15 |
| A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD) (NCT05278104) | Boehringer Ingelheim | 2023-09-14 |
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Zongertinib in the Blood (NCT06028464) | Boehringer Ingelheim | 2023-09-11 |
| Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine (NCT05846230) | Boehringer Ingelheim | 2023-09-08 |
| A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood (NCT05934942) | Boehringer Ingelheim | 2023-09-08 |
| A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis (NCT05741372) | Boehringer Ingelheim | 2023-09-07 |
| A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men (NCT06006598) | Boehringer Ingelheim | 2023-08-28 |
| A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease (NCT05970640) | Boehringer Ingelheim | 2023-08-14 |
| A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body (NCT05879991) | Boehringer Ingelheim | 2023-08-10 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood (NCT05965583) | Boehringer Ingelheim | 2023-08-02 |
| Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease (NCT05957198) | Boehringer Ingelheim | 2023-07-25 |
| A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood (NCT05945888) | Boehringer Ingelheim | 2023-07-25 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated (NCT06139341) | Boehringer Ingelheim | 2023-07-21 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003) (NCT05934955) | Boehringer Ingelheim | 2023-07-13 |
| A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 (NCT05879978) | Boehringer Ingelheim | 2023-06-27 |
| A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men (NCT05857878) | Boehringer Ingelheim | 2023-06-23 |
| A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome (NCT05856526) | Boehringer Ingelheim | 2023-06-12 |
| A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer (NCT05839600) | Boehringer Ingelheim | 2023-06-07 |
| Patients With Geographic Atrophy and Their Patient Journey in the United States (US) (NCT05891275) | Boehringer Ingelheim | 2023-05-31 |
| Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients (NCT05870956) | Boehringer Ingelheim | 2023-05-16 |
| A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma (NCT05846516) | Boehringer Ingelheim | 2023-05-11 |
| A Study in Healthy Men to Test How BI 764198 is Processed in the Body (NCT05863130) | Boehringer Ingelheim | 2023-05-03 |
| A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood (NCT05738291) | Boehringer Ingelheim | 2023-05-01 |
| A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis (NCT05728489) | Boehringer Ingelheim | 2023-04-27 |
| A Study in Healthy Men to Test How BI 1291583 is Processed in the Body (NCT05833035) | Boehringer Ingelheim | 2023-04-24 |
| Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment (NCT05875532) | Boehringer Ingelheim | 2023-04-20 |